Picture of Nykode Therapeutics ASA logo

NYKD — Nykode Therapeutics ASA News Story

0.000.00%
no flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapMomentum Trap

Brief: Nykode Therapeutics Initiates Phase 2 Trial Of Vb10.16

April 19 (Reuters) - Nykode Therapeutics ASA  NYKD.OL :
    * INITIATES PHASE 2 TRIAL OF VB10.16 IN SECOND LINE
HPV16-POSITIVE
CERVICAL CANCER

Source text for Eikon:  ID:nObib1CDga 
Further company coverage:  NYKD.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Nykode Therapeutics ASA

See all news